CIK 0001831828
- Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812744449
- Phone
- +1 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, FINANCE, CHIEF ACCT OFFCR sold 30,837 shares at an average $42.30 ($1,304,435)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale SVP, FINANCE, CHIEF ACCT OFFCR sold 5,714 shares at $40.00 ($228,560)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 118,477 shares at an average $39.58 ($4,689,722)
- 4 Gift CHIEF FINANCIAL OFFICER gave 16,541 shares (gift)
- 4 Open-market sale Director sold 834,459 shares at an average $40.86 ($34,099,583)
- 4 Open-market buy Director bought 161,290 shares at $31.00 ($4,999,990)
- 4 Grant or award PRESIDENT AND CEO acquired 78,750 shares (grant or award)
- 4 Grant or award SVP, FINANCE, CHIEF ACCT OFFCR acquired 21,875 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 26,250 shares (grant or award)
Page 5 of 12 · 230 filings